Clinical Implications of Circulating Tumor DNA in MIBC
Автор: OncUpdates: Latest Oncology Insights
Загружено: 2025-06-16
Просмотров: 879
Описание:
Here we dived into the exciting world of circulating tumor DNA (ctDNA) and its implications in muscle invasive bladder cancer. We discussed with Dr. Petros' about upcoming presentation on the NIAGARA trial, focusing on ctDNA's role both pre-operatively and post-operatively.
We explored the prognostic value of ctDNA and its potential prognostic and predictive capabilities, particularly in relation to immunotherapy. With insights drawn from significant trials like Imvigor010, TOMBOLA, and ABACUS, we highlighted the importance of understanding how ctDNA can inform treatment responses.
Tune in to hear about the largest trial involving this biomarker, which provides critical time points for assessing patient responses to neoadjuvant therapy and beyond. This episode promises to deliver rich information and insights into the future of bladder cancer treatment.
Don't miss out on this informative discussion! Be sure to like, subscribe, and hit the notification bell for more updates on the latest in cancer research.
Follow us on social media:
• X/Twitter: / oncbrothers
• Instagram: / oncbrothers
• Website: https://oncbrothers.com/
• Main Channel: / @oncologybrothers
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
